Merck KGaA Touts “Next Wave of Growth” at JPM Healthcare, Reaffirms 2025 Guidance, Eyes 2026 Upside

She also referenced recent portfolio actions, including the acquisition of SpringWorks and the divestment of Surface Solutions, as well as a “string of pearls” approach to technology additions such as Mirus Bio, UnitySC, and a chromatography business acquired from GSR late last year.Garijo reiterated that Merck operates across three businesses—Healthcare, Life Science, and Electronics—while concentrating investment on the three growth pillars. In Life Science, she highlighted bioprocessing leadership within ...